Snap Chart
Medtech companies are among the most profitable in the healthcare industry, with margins averaging 22%. Innovation in premium products and industry consolidation will help profit pools grow to $72 billion in 2024, a 38% increase from 2019. Surgical instruments and implants and medtech services will show the strongest profit growth. Increased pricing scrutiny may exert some pressure on margins, but better cost management and industry consolidation are expected to help offset these pressures and expand overall margins.
Tim van Biesen leads Bain & Company’s Global Healthcare practice. He is based in the firm’s New York office. Todd Johnson is a partner with Bain’s Healthcare practice and is located in the New York office.
First published in mars 2020